| 注册
首页|期刊导航|中国药理学通报|干扰素抗肿瘤机制及其治疗肿瘤的研究进展

干扰素抗肿瘤机制及其治疗肿瘤的研究进展

张婷婷 仲金秋 曹玉珠 吴佳伟 陈文星 王爱云 陆茵

中国药理学通报2017,Vol.33Issue(9):1195-1199,5.
中国药理学通报2017,Vol.33Issue(9):1195-1199,5.DOI:10.3969/j.issn.1001-1978.2017.09.003

干扰素抗肿瘤机制及其治疗肿瘤的研究进展

Research progress of interferons in cancer treatment and its mechanism

张婷婷 1仲金秋 1曹玉珠 1吴佳伟 1陈文星 1王爱云 2陆茵1

作者信息

  • 1. 南京中医药大学药学院,江苏省中药药效与安全性评价重点实验室,江苏 南京 210023
  • 2. 南京中医药大学江苏省中医药防治肿瘤协同创新中心,江苏 南京 210023
  • 折叠

摘要

Abstract

The interferons(IFNs) are a family of the multifunctional cytokines, which are a kind of highly active and multifunctional glycoproteins.Studies in recent years have shown that IFNs exert a powerful antitumor effect by regulating the proliferation of tumor cells, suppressing tumor metastasis and angiogenesis, and activating antitumor immune response.Combined with other tumor treatment methods, it can inhibit the development of a variety of blood system tumors and solid tumors.In addition, the use of IFNs inducers or IFNs combined with emerging immunotherapy can significantly increase the effectiveness of tumor therapy.This review focuses on our understanding of antitumor mechanism and clinical application of IFNs, and provides some guidance for future research and clinical treatment.

关键词

干扰素/肿瘤/分子机制/转移/免疫/临床治疗

Key words

interferons/tumor/molecular mechanisms/metastasis/immunity/clinical treatment

分类

医药卫生

引用本文复制引用

张婷婷,仲金秋,曹玉珠,吴佳伟,陈文星,王爱云,陆茵..干扰素抗肿瘤机制及其治疗肿瘤的研究进展[J].中国药理学通报,2017,33(9):1195-1199,5.

基金项目

国家自然科学基金资助项目 (No 81403260,81573859,81673725,81673648) (No 81403260,81573859,81673725,81673648)

江苏高校优秀科技创新团队计划[苏教科(2013)10号文] (2013)

江苏高校品牌专业建设工程资助项目(No PPZY2015A070) (No PPZY2015A070)

江苏高校中药学优势学科建设工程资助项目 (PAPD)[苏政办发(2014)37号文] (PAPD)

江苏普通高校研究生科研创新计划项目(No KYZZ15_0271, KYLX_0972) (No KYZZ15_0271, KYLX_0972)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量7
|
下载量0
段落导航相关论文